The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant reductions compared to placebo in mean monthly migraine days (MMDs) within the first 4 weeks, in...
Hence then, the article about new data demonstrates robust efficacy of vyepti eptinezumab in otherwise difficult to treat patients with severe migraine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine )
Also on site :
- 1984 Johnny Depp Movie, With a 94% Rotten Tomatoes Score, Ranked Among ‘Best Horror Movies of All Time’
- 2002 Movie Musical, Starring Renée Zellweger and Catherine Zeta-Jones, Has an 87% Rotten Tomatoes Score and Won Best Picture
- Psychologist Says the 1 Phrase That Instantly Shuts Down an Emotionally Immature Person Isn’t What You Might Think